Used in biomedical research to quantify levels of kynurenine 3-monooxygenase (KMO) in human biological samples such as serum, plasma, or tissue homogenates. This assay helps investigate the role of KMO in the kynurenine pathway, which is linked to neurodegenerative diseases like Alzheimer's and Huntington's disease, as well as psychiatric conditions including depression and schizophrenia. Researchers use the kit to monitor changes in KMO expression in response to experimental treatments, assess immune activation, and explore potential therapeutic targets within the neuroinflammatory pathway. It is a valuable tool in preclinical studies aiming to understand metabolic dysregulation in neurological and immune-related disorders.